P. Rosenzweig et al., THE PLACEBO-EFFECT IN HEALTHY-VOLUNTEERS - INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE ADVERSE EVENTS PROFILE DURING PHASE-I STUDIES, Clinical pharmacology and therapeutics, 54(5), 1993, pp. 578-583
In contrast to the plethora of publications on placebo effects in pati
ents, very tittle is known about placebo effects in healthy volunteers
during clinical pharmacology studies. We therefore reviewed the adver
se events spontaneously reported during placebo administration in 109
double-blind, placebo-controlled studies involving 1228 volunteers. Th
e overall incidence of adverse events in the healthy volunteers during
placebo administration was 19%. As expected, complaints were more fre
quent after repeated dosing (28%) and in elderly subjects (26%). Overa
ll, the most frequent adverse events were headache (7%), drowsiness (5
%), and asthenia (4%), with some variation depending on study design a
nd population. In conclusion, these data shed new light on the impact
of experimental conditions on the results of safety evaluations in hea
lthy volunteers participating in clinical pharmacology studies.